Longeveron Inc
Change company Symbol lookup
Select an option...
LGVN Longeveron Inc
ESINQ ITT Educational Services Inc
EESE Energy and Environmental Services Inc
TXN Texas Instruments Inc
GTH Genetron Holdings Ltd
$NQAT60LMGBPT Nasdaq Austria Energy Large Mid Cap
FICO Fair Isaac Corp
CBDL Cbd Life Sciences Inc
HKXCY Hong Kong Exchanges and Clearing Ltd
TOMZ TOMI Environmental Solutions Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Longeveron Inc. is a clinical stage biotechnology company, which is developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. It is sponsoring phase I and II clinical trials in various indications, such as aging frailty, Alzheimer's disease (AD), metabolic syndrome, acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). It is evaluating Lomecel-B as a therapy for aging frailty and is being designed to reduce inflammation associated with aging frailty and to promote an anti-inflammatory state by releasing anti-inflammatory molecules, which can promote physiological restoration to a more normal state. The Company has completed two multicenter trials in the United States for aging frailty.

Closing Price
$5.94
Day's Change
-0.16 (-2.62%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.41
Day's Low
5.88
Volume
(Average)
Volume:
207,581

10-day average volume:
227,491
207,581

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.